目的：研究黄芪总皂苷（TSA）抗血栓形成作用，探讨其作用机制。
Objective: To research antithrombotic effect and mechanism of total saponins of Astragalus (TSA).
本发明涉及一种黄芪医药制剂，具体为一种黄芪总皂苷氯化钠注射液的制备方法。
The invention relates to a radix astragali pharmaceutical preparation, in particular to a method for preparing a radix astragali total saponin sodium chloride injection.
目的：研究水提法、水提醇沉法、乙醇超生提取法三种提取方法对黄芪总皂苷的影响。
Objective: To study the effects of water extraction, water extract-alcohol precipitation and ethanol ultrasonic extraction on the content of astragalus saponin.
采用HPLC -ELSD法测定了黄芪总皂苷滴丸中黄芪甲苷的含量，进行了方法学考察。
The content of Astragaloside IV in the dropping pills was examined by HPLC-ELSD.
目的：通过对黄芪中有机成分的提取，探讨元素铜与总黄酮（TFA）、多糖（TPA）及总皂苷（TSA）的关系。
Objective: To study the relationship between copper and organic components, total flavonoids of Astragalus(TFA), total saponins of Astragalus(TSA) and total polysaccharide of Astragalus(TPA).
目的探讨三七总皂苷、黄芪防治2型糖尿病动脉粥样硬化的作用机制。
Objective to investigate the role and mechanism of Astragalus (AS) and Panax Notoginseng Saponins (PNS) in treatment of type 2 diabetic atherosclerosis.
目的探讨三七总皂苷、黄芪防治2型糖尿病动脉粥样硬化的作用机制。
Objective to investigate the role and mechanism of Astragalus (AS) and Panax Notoginseng Saponins (PNS) in treatment of type 2 diabetic atherosclerosis.
应用推荐